Archives: Agenda

PANEL DISCUSSION Future of Clinical Trial Professionals: How Technology Is Transforming Workforce Roles and Expectations

  • Reimagining responsibilities across clinical trial functions in an AI- and automation-driven environment
  • Evolving from task-based roles to strategic, insight-driven contributors across operations and data functions
  • Redefining entry-level roles as technology reshapes foundational skills, expectations, and career pathways
  • Identifying the new capabilities required to ensure technology enhances, not replaces the expertise of clinical trial professionals

Advancing Oncology Clinical Trials in the UK: Navigating the Evolving Regulatory Landscape

  • Implementing MHRA and HRA expectations for innovative oncology trial designs (platform, basket and adaptive studies)
  • Integrating biomarkers, companion diagnostics and expedited pathways within the UK regulatory framework (e.g. ILAP, EAMS)
  • Operationalising UK‑specific approvals: interplay of MHRA, HRA/REC, UK GDPR and local R&D for oncology studies
  • Positioning UK oncology trials in a post‑Brexit environment: alignment with EU/ICH standards and leveraging UK flexibility

The Future of RBQM for Early Phase Studies Starts Here

RBQM is essential for protecting patient safety and driving quality by design principles across all phases of clinical research and is arguably more important in early phase studies than any other. Yet in practice, the application of RBQM to early phase is highly inconsistent, often relying on manual processes and individual judgement instead of structured processes, supported by compliant technology.

 

In this session we’ll share where the gaps are in RBQM adoption and implementation, what’s at stake when sponsors get this wrong, as well as how to move forward to implement a rigorous RBQM strategy for your trials. Attendees will leave with actionable insights on how flexible, structured monitoring can:

  • Improve visibility into what’s been reviewed, by whom and why
  • Drive efficiency and consistency without rigidity
  • Enable better decision-making and prioritization across diverse study designs.

 

This session will provide you with a roadmap to bringing early phase studies into the RBQM fold.

TRI TRIALS

Powering Pragmatic Decentralised Trials with Real-World, Real-Time Data

  • Discover how routinely collected healthcare data can power the next generation of pragmatic and decentralised clinical trials.
  • Learn how integrating real-time electronic health record (EHR) data into trial workflows can accelerate recruitment and reduce burden on sites and patients.
  • Explore practical approaches for generating high-quality real-world evidence alongside traditional interventional study data.
  • Gain insight into the technology, governance, and operational partnerships required to deliver scalable, patient-centric research models in practice.
 

Unlocking UK trials through primary care: predictable, accurate and fast recruitment

UK clinical research faces a persistent challenge in translating study design into timely, predictable recruitment at scale. Ongoing variability in feasibility, slow start‑up and fragmented patient identification continue to affect delivery, site workload and participant experience.

In this presentation, Solutions Specialist Isabel Hunt will demonstrate how closer collaboration with primary care, underpinned by comprehensive, coded general practice data, can address these challenges end to end. Using the Recruit solution, embedded within the UK’s leading GP clinical systems, sponsors and CROs can enable predictable, accurate and fast recruitment through improved feasibility, faster identification of eligible patients and trusted GP‑led engagement at scale.

Attendees will learn how Recruit reduces time to first patient in, lowers screen failures, minimises site burden and supports more reliable trial delivery. The session will also explore how secure, consent driven primary care data supports ongoing study delivery and real‑world evidence generation across the UK.

Reserved for Event Sponsor

  • There are many obstacles to running a successful clinical trial – and hospital sites can be one.
  • Slow to set up, delays to patient recruitment, or poor data quality?
  • TCR-Solutions will share some experience and approaches to troubleshooting these challenges.
  • We cannot treat hospital sites like commercial vendors, and we must find a way to work with hospitals to ensure they deliver on time and target.